Search the Newsreel

Perma-Fix Environmental Services Inc (PESI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Perma-Fix Environmental Services Inc (PESI), highlighting its current earnings forecast score, average price target of $20.00, and an analyst rating of "Buy" based on one analyst. It also details expected revenue for the next quarter at $12.90M …

Wall Street Zen Downgrades Kenvue (NYSE:KVUE) to Hold

Wall Street Zen has downgraded Kenvue (NYSE:KVUE) from a "Buy" to a "Hold" rating, reflecting a consensus among analysts. The company's second-quarter revenue grew 3% year-over-year to $3.96 billion, but EPS and revenue slightly missed expectations due to inflationary pressures, tariffs, and currency costs. …

Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 49.8% in the second quarter, selling 3.19 million shares and retaining 3.22 million shares. This move comes as Kenvue reported Q2 sales of $3.96 billion and adjusted EPS of $0.31, both …

Kenvue (KVUE) Stock Holds Firm As Margin Gains Anchor The Story

CDT Environmental Technology Investment Holdings Ltd (CDTG) Stock News Today

This article provides current stock news for CDT Environmental Technology Investment Holdings Ltd (CDTG), noting its recent stock performance with a 13.46% decrease. It indicates that more news will be coming soon regarding earnings, analyst ratings, and key developments for the company.

Noticias de acciones de Kenvue Inc (KVUE)

Senvest Capital Posts Surge in Second-Quarter Earnings

CONCORD ENVIRO SYSTEMS LTD. Share Price Today Down 6%

Perma-Fix (PESI): MAK Capital group discloses 5.5% beneficial ownership

MAK Capital group, including MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman, has disclosed a 5.5% beneficial ownership stake in Perma-Fix Environmental Services Inc. (PESI). This group collectively owns 1,161,372 shares of common stock, representing 5.5% of the 21,203,552 shares …

Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Kenvue (KVUE) reported Q2 earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32, though it represents an increase from $0.29 per share a year ago. The company also missed revenue estimates, posting $3.96 billion against an expected $3.99 billion. Despite these …

Senvest Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Senvest Capital Inc. Posts $415.4 Million Net Income in Q2 2026, Nearly Doubling Earnings from Previous Year

TOMI Environmental Solutions Inc (NASDAQ: TOMZ) Share Price, TOMZ Stock News, TOMZ Share Price & Updates

Sanli Environmental Forms Rail Electrification Joint Venture for Cross Island Line

Enviri Corp (NVRI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Enviri Corp (NVRI) has an earnings forecast score of 7.33, placing it 93rd out of 159 in its industry. Analysts have set an average price target of $21.00, with a consensus indicating a "Buy" trend. The company's expected revenue for the next quarter is …

Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates

NVST vs. ABT: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. …

Kenvue Earnings: Rare Volume Growth Despite Muted US and Europe Performance Impresses

Kenvue reported 3% revenue growth and 7% adjusted EPS growth in the second quarter, driven by 0.7% volume growth despite muted performance in the US and Europe. This volume growth was a rare achievement for the company. Morningstar highlighted this positive performance in their …

Tianjin Capital Signs Connected EPC Deal for Reclaimed Water Projects

Analysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST)

Barclays analysts have offered varied ratings for several healthcare companies. Etzer Darout maintained a Buy rating for Protagonist Therapeutics (PTGX) with a $153.00 price target, while Luke Sergott gave Qiagen (QGEN) a Hold rating with a $38.00 target. Glen Santangelo maintained a Buy rating …

CECO ENVIRONMENTAL Q2 2026 Earnings Preview: Recent $CECO Insider Trading, Hedge Fund Activity, and More

CECO Environmental is set to release its Q2 2026 earnings on August 10th, with analysts projecting $288.86 million in revenue and $0.31 EPS. The article provides a detailed overview of recent insider trading, institutional holdings, government contracts, congressional stock activity, and analyst ratings for …

Kenvue Inc. (KVUE) Stock Forecasts

Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company, having spun off from Johnson & Johnson in May 2023. Recent earnings show rare volume growth despite muted performance in the US and Europe. Analysts continue to evaluate its market position and financial …

Enviro Infra Engineers corrects Q1FY27 earnings call date to August 12

Zonqing Environmental Flags Interim Loss as Major Projects Wind Down

Kenvue (NYSE:KVUE) Posts Earnings Results, Misses Expectations By $0.01 EPS

Kenvue (NYSE:KVUE) reported its quarterly earnings, missing analyst expectations by $0.01 EPS with $0.31 per share, against an estimated $0.32. The company's revenue of $3.96 billion also slightly missed the $3.97 billion forecast but marked a 3.0% increase year-over-year. Kenvue declared a quarterly dividend …

Envista (NVST) Stock Slips Despite Sharper Margins And Strong Cash Flow

Press Release: Kenvue Reports Second Quarter 2026 Results

This document is a press release from Kenvue reporting their second quarter 2026 financial results. Without further content, the specific details of these results are unknown.

Kenvue Inc. stock falls Thursday, underperforms market

Kenvue Inc. (KVUE) stock fell by 2.49% on Thursday, closing at $19.18, and underperformed the broader market. This decline occurred during an overall poor trading session where the S&P 500 Index dropped 0.18% and the Dow Jones Industrial Average fell 0.85%. The stock's fall …

Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Margins

This article first appeared on GuruFocus. Kenvue (NYSE:KVUE), the consumer-health giant behind Tylenol, Neutrogena and Listerine, delivered another quarter of steady growth, but that was not enough to keep investors happy as the stock slid about 2.7% on Thursday. Revenue climbed 3% year over …

Dental company Envista reports 5% core sales growth in Q2

Envista Holdings Corporation (NYSE: NVST) reported strong second-quarter 2026 results, achieving 5.0% core sales growth and a 58% year-over-year increase in adjusted diluted EPS. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth, and adjusted EPS, reflecting confidence in …

Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook

Envista Holdings (NVST) exceeded Wall Street expectations for Q2 2026, reporting adjusted earnings of $0.41 per share on revenue of $730.5 million, surpassing analyst estimates. The company raised its full-year 2026 guidance, citing strong performance across its dental portfolio, increased margins, and robust free …

Capital Environment Wins Connected Qixian Waste Management Tender

KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise

Kenvue Inc. (KVUE) reported its Q2 2026 results, with both adjusted earnings and net sales missing Zacks Consensus Estimates despite showing increases year-over-year. The company experienced narrowing margins due to inflation and foreign exchange, while its Self Care segment returned to organic growth and …

Did Envista's Q2 Beat, Guidance Hike and Buybacks Just Shift Envista Holdings' (NVST) Investment Narrative?

Kenvue second quarter results fall short of expectations, sending shares lower

Kenvue Inc. (NYSE:KVUE) reported second-quarter results that fell slightly below Wall Street expectations, causing its shares to drop by about 2%. The consumer health company reported adjusted diluted earnings per share of $0.31 on revenue of $3.96 billion, missing analyst estimates of $0.32 EPS …

NVST Q2 Deep Dive: Margin Expansion and Product Launches Amid China Market Shifts

Envista Holdings (NYSE:NVST) reported better-than-expected Q2 CY2026 results, with revenue up 7.1% year-on-year to $730.5 million and adjusted EPS beating estimates by 22.1%. The company's performance was driven by balanced growth across geographies, new product launches in endodontics and orthodontics, and margin expansion due …